Thailand Dna Sequencing Market Size & Outlook, 2025-2033
Related Markets
Thailand dna sequencing market highlights
- The Thailand dna sequencing market generated a revenue of USD 95.1 million in 2024 and is expected to reach USD 380.8 million by 2033.
- The Thailand market is expected to grow at a CAGR of 16.8% from 2025 to 2033.
- In terms of segment, consumables was the largest revenue generating product & service in 2024.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
Dna sequencing market data book summary
| Market revenue in 2024 | USD 95.1 million |
| Market revenue in 2033 | USD 380.8 million |
| Growth rate | 16.8% (CAGR from 2025 to 2033) |
| Largest segment | Consumables |
| Fastest growing segment | Services |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, Qiagen NV, Roche Holding AG, Macrogenics Inc, PerkinElmer, Pacific Biosciences of California Inc, BGI Group, BGC Group Inc Ordinary Shares Class A, Bio-Rad Laboratories Inc, Myriad Genetics Inc, PierianDx, Eurofins Scientific SE |
Other key industry trends
- In terms of revenue, Thailand accounted for 0.6% of the global dna sequencing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China dna sequencing market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 9,479.3 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
DNA Sequencing Market Scope
DNA Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BGC Group Inc Ordinary Shares Class A | View profile | 3895 | 499 Park Avenue, New York, NY, United States, 10022 | https://www.bgcg.com |
| BGI Group | View profile | 5001-10000 | Shenzhen, Guangdong, China, Asia | https://www.genomics.cn/ |
| PierianDx | View profile | 51-100 | St Louis, Missouri, United States, North America | https://www.pieriandx.com |
| Pacific Biosciences of California Inc | View profile | 796 | 1305 O’Brien Drive, Menlo Park, CA, United States, 94025 | https://www.pacb.com |
| Macrogenics Inc | View profile | 339 | 9704 Medical Center Drive, Rockville, MD, United States, 20850 | https://www.macrogenics.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Myriad Genetics Inc | View profile | 2700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | https://www.myriad.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Thailand dna sequencing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna sequencing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 57.2% in 2024. Horizon Databook has segmented the Thailand dna sequencing market based on consumables, instruments, services covering the revenue growth of each sub-segment from 2021 to 2033.
Increasing investments by the Thai government along with the growing market are responsible for the country becoming a hub for precision medicine and genomic projects. Some of the projects undertaken by the Thailand government are Genomics Thailand Initiative launched in 2019, National Biobank of Thailand (NBT) established in 2019, and the Southeast Asian genome-sequencing project.
Over the past few years, the CDC and Ministry of Public Health in Thailand are working on developing intervention strategies to fight against high-risk diseases. The prevalence of cancer has increased in the country, accounting for 19% of the overall deaths, followed by 12% of deaths due to ischemic heart disease and 10% due to stroke.
Moreover, increase in the incidence of infectious diseases such as hepatitis, diarrhea, dengue fever, malaria, Japanese encephalitis, HIV, leptospirosis, and rabies is expected to fuel the demand for NGS technologies for proper diagnosis & treatment.
Reasons to subscribe to Thailand dna sequencing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Thailand dna sequencing market databook
-
Our clientele includes a mix of dna sequencing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand dna sequencing market , including forecasts for subscribers. This country databook contains high-level insights into Thailand dna sequencing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Thailand dna sequencing market size, by product & service, 2021-2033 (US$M)
Thailand DNA Sequencing Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
